Navigation Links
Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process
Date:11/18/2011

LOS ANGELES, Nov. 18, 2011 /PRNewswire/ -- Qmed.com, the world's only 100% qualified medical device supplier directory, search engine, and central industry resource, today announced a new powerful business intelligence tool is now live on the Qmed site as part of its continuing commitment to provide users with additional resources.

(Logo: http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)

"I am very pleased to announce that this new regulatory and product development tool is now available to all Qmed users," stated Tim Simone, Qmed Brand Director.  "This is just one example of the many ways we continue to enhance Qmed and provide users with the most relevant, time-saving, and cost-effective tools. Qmed is dedicated to providing the medical device industry with resources and information that assist in the development of life-saving medical technologies."

This new resource listed under Regulatory Tool on the Qmed Resources tab, provides Qmed users exclusive access to proprietary e-Zassi software. Part of the tool, free only to Qmed users, is powered by a database of information on classified medical devices. After the user enters information regarding their current project, this tool then searches and provides potential predicate codes and pathway for medical technology in Cardiovascular, Orthopedic, Gastroenterology & Urology, General/Plastic Surgery and Radiological devices.

A full report is also available to Qmed users at a greatly discounted rate exclusively only on Qmed.com. This extensive version calculates the future development and commercialization milestones of a new medical technology. It also provides insight into the pivotal product development hurdles that affect medical device product decision making. The software does not utilize any confidential information, allowing the information to be shared with business partners and vendors, regardless of patent status.

Learn more and access the new resources on Qmed here.

About Qmed

Qmed is the world's ONLY 100% qualified medical device supplier directory, search engine and industry resource, created exclusively for OEMs actively researching and sourcing qualified suppliers, products, and services during the product design cycle. Powered by advanced keyword search and embedded with relevant supplier and industry content, rich media, and RFP opportunities, Qmed is the critical resource used to connect medical device OEMs with qualified suppliers. From medical contract manufacturers to stock component suppliers and medical device consultancies, Qmed's powerful search tool, directory, and white paper library serves only relevant, editorially screened supplier listings and resources to provide the most efficient supplier-sourcing experience for medical device OEMs. Qualified suppliers are determined by verification of the following criteria: currently working with medical device OEMs, exhibit at medical device industry trade shows, are GMP compliant, ISO 9000, and/or FDA–registered.

About UBM Canon

UBM Canon, the leading B2B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM plc (UBM.L) a global provider of media and information services for professional B2B communities and markets.

About e-Zassi

e-Zassi is the first Innovation Management (IM) software platform designed to address the needs of the patent centric medical device industry. The platform delivers a standardized approach to the submission, capture, decision support and sharing of ideas, in a non-confidential assessment format that minimizes intellectual property disclosure risks. The suite of web-based software solutions delivers critical business intelligence on product development and commercialization burdens associated with a new med-tech application. The outputs are generated in real time and immediately available to the user driving better decision making, due diligence and increased business development efficiency.


'/>"/>
SOURCE UBM Canon
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. QMed, Inc. Receives 2-Year Extension of Medicare Coordinated Care Demonstration Project by CMS
2. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
3. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
4. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
5. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
6. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
7. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
8. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
9. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
10. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
11. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):